Harpreet S. Dhaliwal - Dec 28, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP Cml Mfg & Supply Chain
Signature
Harpreet S. Dhaliwal, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Dec 28, 2022
Transactions value $
$99,989
Form type
4
Date filed
12/30/2022, 03:28 PM
Previous filing
Sep 7, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $100K +3.99K +22.39% $25.06 21.8K Dec 28, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (Right to Buy) Disposed to Issuer $0 +3.99K +4.34% $0.00 96K Dec 28, 2022 Common Stock 3.99K $25.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 928 shares acquired under the Vaxcyte, Inc. Employee Stock Purchase Plan on November 17, 2022.
F2 1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.